Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 584209Generated: October 31, 2026

Formaldehyde → (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(3,4-dimethylbenzyl) 4-[4-(3,3-dimethylmorpholino)-2-butynyl]piperazine dihydrochloride

https://huagongshe.com/reaction/584209

Reaction equation

Participants

RoleNameHCIDCharge
ReactantFormaldehydeHCID 712—
ReactantPotassium IodideHCID 4875—
ReactantSodium BicarbonateHCID 516892—
Reactant3,3-Dimethyl-4-(2-propynyl)morpholine hydrochlorideHCID 22342701—
Reactant(2R)-[3,5-bis(trifluoromethyl)benzoyl]-2-(3,4-dimethylbenzyl)piperazineHCID 54478438—
CatalystCopper sulfate pentahydrateHCID 24463—
Solvent1,4-DioxaneHCID 31275—
Product(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(3,4-dimethylbenzyl) 4-[4-(3,3-dimethylmorpholino)-2-butynyl]piperazine dihydrochlorideHCID 86588519—

Reaction Conditions

Temperature90 °C

Reaction Steps

A mixture of 3,3-dimethyl-4-(2-propynyl)morpholine hydrochloride (0.24 g), 37% aqueous formaldehyde (0.16 ml), (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(3,4-dimethylbenzyl)piperazine (0.57 g), copper(II) sulfate pentahydrate (5 mg) and potassium iodide (20 mg) in 1,4-dioxane (0.7 ml) was stirred at 90° C. for 1 hour. After being cooled to room temperature, the mixture was poured into ice-water and the aqueous mixture was made alkaline with saturated aqueous sodium hydrogen carbonate solution. The resulting mixture was extracted with ethyl acetate. The extract was washed with brine, dried over magnesium sulfate and evaporated under reduced pressure. The residue was purified by column chromatography on silica gel using a mixed solvent of dichloromethane and methanol (40:1). The fractions containing the objective compound was collected and evaporated under reduced pressure and treated with 4N hydrogen chloride in ethyl acetate solution. The resulting mixture was evaporated under reduced pressure and the residue was recrystallized from a mixture of acetone and water to give colorless crystals of (2R)-1-[3,5-bis(trifluoromethyl) benzoyl]-2-(3,4-dimethylbenzyl)-4-[4-(3,3-dimethyl-morpholino)-2-butynyl]piperazine dihydrochloride (0.64 g).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06924278B2
Source datasetuspto-grants-2005_08
ORD IDord-9369211a5b604872a279de101c3e74f7
Source noteuspto-grants-2005_08